During the past decade, Hematology and Oncology of Northeast Georgia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology and Oncology of Northeast Georgia" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hematology and Oncology of Northeast Georgia" are "Bladder Cancer" (2 trials), "Kidney Cancer" (1 trials), "Transitional Cell Cancer of the Renal Pelvis and Ureter" (1 trials) and "Urethral Cancer" (1 trials). Many other conditions were trialed in "Hematology and Oncology of Northeast Georgia" in a lesser frequency.

Most popular intervention types in "Hematology and Oncology of Northeast Georgia" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (2 trials), "bevacizumab" (1 trials), "cisplatin" (1 trials), "doxorubicin hydrochloride" (1 trials) and "filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology and Oncology of Northeast Georgia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hematology and Oncology of Northeast Georgia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hematology and Oncology of Northeast Georgia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hematology and Oncology of Northeast Georgia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".